M
Meena Khandelwal
Researcher at Cooper University Hospital
Publications - 44
Citations - 2251
Meena Khandelwal is an academic researcher from Cooper University Hospital. The author has contributed to research in topics: Pregnancy & Placenta accreta. The author has an hindex of 18, co-authored 35 publications receiving 2062 citations. Previous affiliations of Meena Khandelwal include Cooper Hospital & Rutgers University.
Papers
More filters
Journal ArticleDOI
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial
Sonia S. Hassan,Sonia S. Hassan,Roberto Romero,Roberto Romero,Roberto Romero,D. Vidyadhari,S. Fusey,Jason K. Baxter,Meena Khandelwal,J. Vijayaraghavan,Y. Trivedi,Priya Soma-Pillay,P. Sambarey,Ashlesha K. Dayal,V. Potapov,John M. O'Brien,John M. O'Brien,V. Astakhov,O. Yuzko,W. Kinzler,B. Dattel,H. Sehdev,L. Mazheika,D. Manchulenko,M. T. Gervasi,Lisa M. Sullivan,Agustin Conde-Agudelo,James A. Phillips,George W. Creasy +28 more
TL;DR: The efficacy and safety of using micronized vaginal progesterone gel to reduce the risk of preterm birth and associated neonatal complications in women with a sonographic short cervix is determined.
Journal ArticleDOI
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial
John M. O'Brien,Charles Adair,David F. Lewis,David Hall,Emily DeFranco,S. Fusey,Priya Soma-Pillay,Kathy B. Porter,Helen How,R. Schackis,D. Eller,Y. Trivedi,G. Vanburen,Meena Khandelwal,Kenneth F. Trofatter,D. Vidyadhari,J. Vijayaraghavan,J. Weeks,B. Dattel,E. Newton,C. Chazotte,G. Valenzuela,Pavel Calda,M. Bsharat,George W. Creasy +24 more
TL;DR: The objective of this trial was to determine whether prophylactic administration of vaginal progesterone reduces the risk of preterm birth in women with a history of spontaneous pre term birth.
Journal ArticleDOI
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix : a secondary analysis from a randomized, double-blind, placebo-controlled trial
Emily DeFranco,John M. O'Brien,Charles Adair,David F. Lewis,David Hall,S. Fusey,Priya Soma-Pillay,Kathy B. Porter,Helen How,R. Schakis,D. Eller,Y. Trivedi,G. Vanburen,Meena Khandelwal,Kenneth F. Trofatter,D. Vidyadhari,J. Vijayaraghavan,J. Weeks,B. Dattel,E. Newton,C. Chazotte,G. Valenzuela,Pavel Calda,M. Bsharat,George W. Creasy +24 more
TL;DR: To investigate the efficacy of vaginal progesterone to prevent early preterm birth in women with sonographic evidence of a short cervical length in the midtrimester, a large number of studies have found it to be safe and effective.
Journal ArticleDOI
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): A multinational open-label randomised trial
Marc A. Rodger,Marc A. Rodger,William M. Hague,John Kingdom,Susan R. Kahn,Alan Karovitch,Mathew Sermer,Anne Marie Clement,Suzette Coat,Wee-Shian Chan,Joanne M Said,Evelyne Rey,Susan A. Robinson,Rshmi Khurana,Christine Demers,Michael J. Kovacs,Susan Solymoss,Kim Hinshaw,James Dwyer,Graeme N. Smith,Sarah D. McDonald,Jill Newstead-Angel,Anne McLeod,Meena Khandelwal,Robert M. Silver,Grégoire Le Gal,Grégoire Le Gal,Ian A. Greer,Erin Keely,Erin Keely,Karen Rosene-Montella,Mark Walker,Philip S. Wells,Philip S. Wells +33 more
TL;DR: Dalteparin did not reduce the incidence of the primary composite outcome in both intention-to-treat and on-treatment analyses, and the occurrence of major bleeding did not differ between the two groups.
Journal ArticleDOI
Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia
TL;DR: STBMs in maternal blood induce neutrophils to generate superoxide radicals that may cause endothelial dysfunction in women with preeclampsia, and dose-response relationships were observed.